))
Biopharma Perspective on Early Venture Investing and R&D
Manage episode 154229730 series 1116730
Contenido proporcionado por Columbia Tech Ventures and Columbia Technology Ventures. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Columbia Tech Ventures and Columbia Technology Ventures o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Presenting a panel discussion with Marian Nakada (Johnson & Johnson Innovation – JJDC), Bob Silverman (Roche) and Steven Weinstein (Novartis Ventures), moderated by CTV’s executive director Orin Herskowitz. The conversation touches on the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventures, university research sponsorship, and IP licensing to source their next blockbuster products (as well as generate equity returns). The panelists share their perspectives on venture capital investing strategies in biopharma, how to pitch strategic investors, the surge in biotech IPOs, hot research areas within biopharma, and best practices for establishing R&D partnerships between industry and academia.
…
continue reading
15 episodios
Compartir
